A detailed history of Money Concepts Capital Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Money Concepts Capital Corp holds 94,314 shares of GILD stock, worth $8.86 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
94,314
Previous 96,286 2.05%
Holding current value
$8.86 Million
Previous $6.61 Million 19.66%
% of portfolio
0.63%
Previous 0.59%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$66.59 - $83.99 $131,315 - $165,628
-1,972 Reduced 2.05%
94,314 $7.91 Million
Q2 2024

Aug 02, 2024

BUY
$63.15 - $72.88 $97,629 - $112,672
1,546 Added 1.63%
96,286 $6.61 Million
Q1 2024

May 01, 2024

SELL
$71.58 - $87.29 $565,338 - $689,416
-7,898 Reduced 7.7%
94,740 $6.94 Million
Q4 2023

Feb 12, 2024

SELL
$73.27 - $83.09 $151,522 - $171,830
-2,068 Reduced 1.98%
102,638 $8.31 Million
Q3 2023

Oct 31, 2023

BUY
$73.94 - $80.67 $369,108 - $402,704
4,992 Added 5.01%
104,706 $7.85 Million
Q2 2023

Jul 31, 2023

SELL
$76.01 - $86.7 $10.4 Million - $11.9 Million
-137,427 Reduced 57.95%
99,714 $7.68 Million
Q1 2023

May 01, 2023

SELL
$77.31 - $88.08 $3.73 Million - $4.25 Million
-48,303 Reduced 16.92%
237,141 $19.7 Million
Q4 2022

Feb 14, 2023

SELL
$62.32 - $89.47 $98,964 - $142,078
-1,588 Reduced 0.55%
285,444 $24.5 Million
Q3 2022

Oct 27, 2022

BUY
$59.54 - $68.01 $11 Million - $12.6 Million
185,218 Added 181.92%
287,032 $17.7 Million
Q2 2022

Jul 18, 2022

SELL
$57.72 - $65.01 $80,173 - $90,298
-1,389 Reduced 1.35%
101,814 $6.35 Million
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $84,215 - $105,531
-1,454 Reduced 1.39%
103,203 $6.14 Million
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $310,840 - $352,809
4,791 Added 4.8%
104,657 $7.6 Million
Q1 2021

May 17, 2021

BUY
$60.0 - $68.46 $4.34 Million - $4.96 Million
72,393 Added 263.51%
99,866 $6.45 Million
Q4 2020

May 17, 2021

BUY
$56.65 - $64.55 $1.56 Million - $1.77 Million
27,473 New
27,473 $1.6 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Money Concepts Capital Corp Portfolio

Follow Money Concepts Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Money Concepts Capital Corp with notifications on news.